Changing Hepatitis B Virus Epidemiology in Rural China – Authors' Reply

Min Lee,Shikun Zhang,Jue Liu,Qiaomei Wang,Haiping Shen

DOI: https://doi.org/10.1016/s1473-3099(16)00011-6

2016-01-01

Abstract:We appreciate Jördis Ott and colleagues' and Yi-Hua Zhou's comments on our Article1Liu J Zhang S Wang Q et al.Seroepidemiology of hepatitis B virus infection in 2 million men aged 21–49 years in rural China: a population-based, cross sectional study.Lancet Infect Dis. 2015; 16: 80-86Summary Full Text Full Text PDF PubMed Scopus (148) Google Scholar about hepatitis B virus in 2 million men in rural China. As mentioned in our Article, data for hepatitis B virus infection in men of a reproductive age in rural China is scarce and the last report about this was in 2006.2Liang X Bi S Yang W et al.Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination.Vaccine. 2009; 27: 6550-6557Crossref PubMed Scopus (742) Google Scholar, 3The Ministry Of Health Disease Control BureauChinese Center for Disease Control and PreventionThe report of a national sero-epidemiological survey of hepatitis B virus infection in the whole population in China, 2006. People's Medical Publishing House, Beijing2011Google Scholar Our data was from the National Free Preconception Health Examination Project (NFPHEP) launched by the Chinese National Health and Family Planning Commission. The NFPHEP provides an opportunity to provide counselling for individuals with hepatitis B virus about how to prevent disease transmission and progression and identify and vaccinate susceptible contacts.4Vellozzi C Averhoff F An opportunity for further control of hepatitis B in China?.Lancet Infect Dis. 2015; 16: 10-11Summary Full Text Full Text PDF PubMed Scopus (11) Google Scholar Our results showed that hepatitis B surface antigen (HBsAg) prevalence in rural men aged 21–49 years was 5·5–6·5%, which was lower than the prevalence in the 21–49 year old group (7·7–12·0%) in the 2006 national survey.2Liang X Bi S Yang W et al.Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination.Vaccine. 2009; 27: 6550-6557Crossref PubMed Scopus (742) Google Scholar, 3The Ministry Of Health Disease Control BureauChinese Center for Disease Control and PreventionThe report of a national sero-epidemiological survey of hepatitis B virus infection in the whole population in China, 2006. People's Medical Publishing House, Beijing2011Google Scholar Participants in our study were in the 15–44 year old group in 2006 by birth cohort. HBsAg prevalence in our study was also lower than the prevalence in the 15–44 year old group (6·4–12·0%) reported by Xiaofeng Liang and colleagues in the 2006 national survey.2Liang X Bi S Yang W et al.Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination.Vaccine. 2009; 27: 6550-6557Crossref PubMed Scopus (742) Google Scholar, 3The Ministry Of Health Disease Control BureauChinese Center for Disease Control and PreventionThe report of a national sero-epidemiological survey of hepatitis B virus infection in the whole population in China, 2006. People's Medical Publishing House, Beijing2011Google Scholar Hence our interpretation about the changing hepatitis B virus endemic in men in rural China is reasonable. As for the discrepancy (eg, reversed association of HBsAg with education) with the results reported by Liang and colleagues, we have explained this in the Discussion section in our Article. Ott and colleagues raise concerns about the minor difference in HBsAg prevalence between vaccinated and non-vaccinated participants. The implementation of the universal hepatitis B vaccination programme for infants was started in 1992 in China; however, the participants in our study were born from 1961 to 1991, and did not benefit from the universal hepatitis B vaccination policy for infants. They were vaccinated voluntarily at their own cost, yet their history of hepatitis B vaccination was not recorded. Hence, vaccination history was self-reported by the participants based on their memory in our study. Recall bias seemed unavoidable to some extent. We have mentioned this point in the limitation part of our Discussion. Zhou questioned the sensitivity of ELISA kits manufactured in China. All the reagent kits selected by 220 counties in our study were tested by the National Center of Clinical Laboratories for Quality Inspection and Detection with reagents produced by Abbott, USA, as the reference standard. Sensitivity, specificity, and kappa values of the selected reagents were above 95%. As for quality control, an external quality assessment process was done twice a year. The accuracy rates of detection were 97·4% for HBsAg, 98·6% for hepatitis B surface antibody, 98·3% for hepatitis B e antigen, 97·6% for anti-hepatitis B e antibody, and 94·5% for anti-hepatitis B core antibody. The test sensitivity is similar to that of previous studies,2Liang X Bi S Yang W et al.Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination.Vaccine. 2009; 27: 6550-6557Crossref PubMed Scopus (742) Google Scholar, 3The Ministry Of Health Disease Control BureauChinese Center for Disease Control and PreventionThe report of a national sero-epidemiological survey of hepatitis B virus infection in the whole population in China, 2006. People's Medical Publishing House, Beijing2011Google Scholar which also used ELISA kits manufactured in China. We declare no competing interests. Seroepidemiology of hepatitis B virus infection in 2 million men aged 21–49 years in rural China: a population-based, cross-sectional studyHBV prevalence in men in rural China has changed from highly endemic into intermediate endemic in the past two decades. However, the absolute number of HBV-infected men and the susceptible population is still very large. Full-Text PDF Changing hepatitis B virus epidemiology in rural ChinaJue Liu and colleagues1 provide new estimates of hepatitis B virus prevalence in rural Chinese men, stratified by important variables such as age and region. The reported prevalence corresponds to the pooled estimate for China from a global assessment of HBsAg prevalence.2 Full-Text PDF Changing hepatitis B virus epidemiology in rural ChinaI read with interest the article by Jue Liu and colleagues1 about the seroepidemiology of hepatitis B virus infection in Chinese men aged 21–49 years in rural China. The authors reported that, of the 1 966 013 tested sera, 124 274 (6%) were positive for hepatitis B surface antigen (HBsAg), indicating the current prevalence of hepatitis B virus infection. Were all these HBsAg-positive people chronically infected? Persistence of HBsAg positivity for at least 6 months is the criterion for chronic infection. Full-Text PDF